← FDA DRUG APPROVALS

FDA ANDA · ANDA077275

DIDANOSINE

Sponsor: AUROBINDO

APPLICATION
ANDA077275
TYPE
ANDA
ORIGINAL APPROVAL
2012-08-14
LATEST ACTION
2012-08-14
ROUTE
ORAL
DOSAGE FORM
TABLET, FOR SUSPENSION
MARKETING STATUS
Discontinued

Products

DIDANOSINEDiscontinued
DIDANOSINE 150MG · TABLET, FOR SUSPENSION · ORAL
DIDANOSINEDiscontinued
DIDANOSINE 200MG · TABLET, FOR SUSPENSION · ORAL
DIDANOSINEDiscontinued
DIDANOSINE 100MG · TABLET, FOR SUSPENSION · ORAL

Approval history

2012-08-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →